Coronaviruses (CoVs) pose a major threat to public health security because no drugs or vaccines are currently approved for the treatment of human CoVs. With the continuous outbreak of SARS-CoV-2 (novel coronavirus, formerly 2019-nCoV), how to rapidly develop therapeutics to prevent and control Coronavirus Disease 2019 (COVID-19) has become a hot issue of global concern. And the outbreak will intensify efforts by the biomedical industry to research and develop drugs for infectious diseases. As a leading provider of contract research services for structural biology projects, Creative Biostructure is committed to structural and computational drug discovery against targets to facilitate the development of antiviral drugs for human CoVs.